No reductions seen in 28-day mortality or duration of hospital stay in COVID-19 with lopinavir-ritonavir
If enough people in the U.S. pass on vaccine, the nation may not be able to achieve herd immunity
No clinical benefit seen versus placebo for hospital-based health care workers exposed to patients with COVID-19
Authors caution that daily low-dose aspirin is linked to more late-stage cancers, related deaths in elderly
In older adults, interactions with meds for depression, anxiety increase risk for ED visits, hospitalizations
Higher case fatality rates found to be independent of demographic factors, such as age, sex, and race
Agency says it is especially true in enclosed spaces with inadequate ventilation
MIS-A related to SARS-CoV-2 infection resembles MIS in children; respiratory symptoms often minimal
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis
Fifty percent of phase 3 clinical trials and 100 percent of vaccine trials at risk for excluding older adults